564.64
price down icon1.35%   -7.75
after-market Dopo l'orario di chiusura: 564.64
loading

Regeneron Pharmaceuticals Inc Borsa (REGN) Ultime notizie

pulisher
07:47 AM

Regeneron Pharmaceuticals Inc. Stock Analysis and ForecastExceptional stock performance - PrintWeekIndia

07:47 AM
pulisher
06:59 AM

Los Angeles Capital Management LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

06:59 AM
pulisher
06:30 AM

Regeneron Pharmaceuticals to Acquire 23andMe for $256M - MSN

06:30 AM
pulisher
04:22 AM

BID aprueba préstamos por 1.200 million dlrs para Argentina - Yahoo Finanzas

04:22 AM
pulisher
03:22 AM

Private Advisor Group LLC Raises Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

03:22 AM
pulisher
12:21 PM

Regeneron and Intellia’s Gene Therapy Study: A Potential Game-Changer for Hemophilia B - TipRanks

12:21 PM
pulisher
12:12 PM

Regeneron and Sanofi’s EoE Study with DUPIXENT®: Key Insights for Investors - The Globe and Mail

12:12 PM
pulisher
10:53 AM

September 5th Options Now Available For Regeneron Pharmaceuticals (REGN) - Nasdaq

10:53 AM
pulisher
08:53 AM

Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory - MSN

08:53 AM
pulisher
08:25 AM

Longleaf Partners Fund Increased its Holdings in Regeneron Pharmaceuticals (REGN) on a Dip - Insider Monkey

08:25 AM
pulisher
08:21 AM

Pinnacle Associates Ltd. Has $51.38 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

08:21 AM
pulisher
07:47 AM

Regeneron Announces the 2025 Winners of the Regeneron Prize for Creative Innovation - The Manila Times

07:47 AM
pulisher
05:55 AM

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Bank Julius Baer & Co. Ltd Zurich - MarketBeat

05:55 AM
pulisher
03:22 AM

Los precios industriales de España suben un 0,8% interanual en junio - Yahoo Finanzas

03:22 AM
pulisher
02:54 AM

Where are the Opportunities in (REGN) - news.stocktradersdaily.com

02:54 AM
pulisher
Jul 23, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Morse Asset Management Inc - MarketBeat

Jul 23, 2025
pulisher
Jul 23, 2025

Regeneron Pharmaceuticals (NASDAQ:REGN) Shares Acquired Rep. Robert Bresnahan, Jr. - MarketBeat

Jul 23, 2025
pulisher
Jul 23, 2025

Regeneron Pharmaceuticals' (REGN) Buy Rating Reaffirmed at Canaccord Genuity Group - MarketBeat

Jul 23, 2025
pulisher
Jul 23, 2025

ANI Pharma stock drops on trial setback (ANIP:NASDAQ) - Seeking Alpha

Jul 23, 2025
pulisher
Jul 23, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Legato Capital Management LLC - MarketBeat

Jul 23, 2025
pulisher
Jul 23, 2025

Atopic Dermatitis Market Forecast Report 2025-2034 | FDA Approval of Tralokinumab-Ldrm Stimulates Treatment Advances - Yahoo Finance

Jul 23, 2025
pulisher
Jul 23, 2025

Balentine LLC Invests $680,000 in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Jul 23, 2025
pulisher
Jul 23, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by Massachusetts Financial Services Co. MA - MarketBeat

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Regeneron Pharmaceuticals Inc. stockPhenomenal returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Regeneron Pharmaceuticals Inc. stock priceFree Stock Selection - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Regeneron's Trading Volume Surges 40.54% to $546 Million Ranking 212th in Stock Market - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

Metastatic Castration-Resistant Prostate Cancer Clinical - openPR.com

Jul 22, 2025
pulisher
Jul 22, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Victory Capital Management Inc. - MarketBeat

Jul 22, 2025
pulisher
Jul 22, 2025

Metastatic Castration-Resistant Prostate Cancer Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | Surface Oncology, Regeneron Pharmaceuticals - Barchart.com

Jul 22, 2025
pulisher
Jul 22, 2025

Beacon Investment Advisory Services Inc. Raises Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Jul 22, 2025
pulisher
Jul 22, 2025

M. Kulyk & Associates LLC Acquires 528 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Jul 22, 2025
pulisher
Jul 22, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Lowered by Edgestream Partners L.P. - MarketBeat

Jul 22, 2025
pulisher
Jul 22, 2025

Regeneron’s New Trial: A Game-Changer for Lung Cancer Treatment? - The Globe and Mail

Jul 22, 2025
pulisher
Jul 22, 2025

Universal Beteiligungs und Servicegesellschaft mbH Sells 21,337 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Jul 22, 2025
pulisher
Jul 22, 2025

Y Intercept Hong Kong Ltd Has $6.16 Million Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Jul 22, 2025
pulisher
Jul 22, 2025

Evergreen Wealth Management LLC Invests $3.59 Million in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Jul 22, 2025
pulisher
Jul 21, 2025

Neutralizing Antibody Market Surges with Monoclonal Therapy & - openPR.com

Jul 21, 2025
pulisher
Jul 21, 2025

South Dakota Investment Council Buys New Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Jul 21, 2025
pulisher
Jul 20, 2025

Is Regeneron Pharmaceuticals Inc. a good long term investmentHigh-yield growth strategies - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

678 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Acquired by AustralianSuper Pty Ltd - MarketBeat

Jul 20, 2025
pulisher
Jul 20, 2025

Apollon Wealth Management LLC Boosts Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Jul 20, 2025
pulisher
Jul 20, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by Cullen Frost Bankers Inc. - MarketBeat

Jul 20, 2025
pulisher
Jul 19, 2025

Regeneron Pharmaceuticals Stock: Is Wall Street Bullish or Bearish? - MSN

Jul 19, 2025
$328.00
price up icon 0.72%
$591.74
price up icon 2.84%
biotechnology ONC
$296.46
price up icon 0.55%
$114.57
price down icon 0.03%
$27.57
price down icon 1.57%
Capitalizzazione:     |  Volume (24 ore):